Sawai Pharmaceutical chief eyes hefty increase in generic output

Sawai Pharmaceutical chief eyes hefty increase in generic output

Mitsuo Sawai, president of major Japanese generic drug maker Sawai Pharmaceutical Co., speaks to Kyodo News in Osaka, western Japan, on Sept. 18, 2015, about a plan to sharply expand its capacity to produce generic drugs. (Kyodo) ==Kyodo

  • Product Code
  • ILEA000048495
  • Registered date
  • 2015/9/25 15:30:57
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • Media size
  • 2099 × 2875 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 799.58(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Fujifilm President Kenji Sukeno

    Fujifilm President Kenji Sukeno

    Fujifilm Corp. President Kenji Sukeno tells a press conference in Toyama on Feb. 22, 2018, that a subsidiary will manufacture so-called liposome drugs for cancer treatment at a facility to be built in the central Japan city. (Kyodo) ==Kyodo
      Takeda to buy U.S. cancer drug maker ARIAD Pharmaceuticals

      Takeda to buy U.S. cancer drug maker ARIAD Pharmaceuticals

      File photo taken in October 2010 shows the Tokyo headquarters of Takeda Pharmaceutical Co. The firm said on Jan. 9, 2017, that it will buy Massachusetts-based ARIAD Pharmaceuticals Inc. in a deal valued at $5.2 billion to expand its cancer treatment business. (Kyodo) ==Kyodo
        Sawai Pharmaceutical chief eyes hefty increase in generic output

        Sawai Pharmaceutical chief eyes hefty increase in generic output

        Mitsuo Sawai, president of major Japanese generic drug maker Sawai Pharmaceutical Co., speaks to Kyodo News in Osaka, western Japan, on Sept. 18, 2015, about a plan to sharply expand its capacity to produce generic drugs. (Kyodo) ==Kyodo